New results detail J&J Embotrap design’s first-pass performance in stroke patients
November 23, 2022 By Jim Hammerand Johnson & Johnson (NYSE:JNJ) has released results for its Embotrap stent retrievers showing the next-generation design’s success in removing blood clots from ischemic stroke patients. Johnson & […]
New results detail J&J Embotrap design’s first-pass performance in stroke patients Read More »
Trebuie să fii autentificat pentru a publica un comentariu.